BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 38563333)

  • 1. NF-E2-related factor 2, a key inducer of antioxidant defenses, negatively regulates the CFTR transcription.
    René C; Lopez E; Claustres M; Taulan M; Romey-Chatelain MC
    Cell Mol Life Sci; 2010 Jul; 67(13):2297-309. PubMed ID: 20309604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.
    Pettit RS
    Ann Pharmacother; 2012; 46(7-8):1065-75. PubMed ID: 22739718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivacaftor for the treatment of cystic fibrosis in children under six years of age.
    Aoyama BC; Mogayzel PJ
    Expert Rev Respir Med; 2020 Jun; 14(6):547-557. PubMed ID: 32154747
    [No Abstract]   [Full Text] [Related]  

  • 4. Ivacaftor attenuates gentamicin-induced ototoxicity through the CFTR-Nrf2-HO1/NQO1 pathway.
    Hu R; Wu F; Zheng YQ
    Redox Rep; 2024 Dec; 29(1):2332038. PubMed ID: 38563333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of Nrf2 in age-related hearing loss and gentamicin ototoxicity.
    Hoshino T; Tabuchi K; Nishimura B; Tanaka S; Nakayama M; Ishii T; Warabi E; Yanagawa T; Shimizu R; Yamamoto M; Hara A
    Biochem Biophys Res Commun; 2011 Nov; 415(1):94-8. PubMed ID: 22020098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPO Attenuates Cisplatin-Induced Ototoxicity in HEI-OC1 Auditory Cell Via the Nrf2-ARE Signaling Pathway.
    Sun C; Yao Y; Zhang C; Tong D; Xie B
    Otol Neurotol; 2019 Aug; 40(7):965-971. PubMed ID: 31135681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zedoarondiol Attenuates Endothelial Cells Injury Induced by Oxidized Low-Density Lipoprotein via Nrf2 Activation.
    Mao H; Tao T; Wang X; Liu M; Song D; Liu X; Shi D
    Cell Physiol Biochem; 2018; 48(4):1468-1479. PubMed ID: 30064139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol pretreatment attenuates injury and promotes proliferation of neural stem cells following oxygen-glucose deprivation/reoxygenation by upregulating the expression of Nrf2, HO-1 and NQO1 in vitro.
    Shen C; Cheng W; Yu P; Wang L; Zhou L; Zeng L; Yang Q
    Mol Med Rep; 2016 Oct; 14(4):3646-54. PubMed ID: 27573874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CFTR potentiator ivacaftor protects against noise-induced hair cell loss by increasing Nrf2 and reducing oxidative stress.
    Wu F; Hu R; Huang X; Lou J; Cai Z; Chen G; Zhao W; Xiong H; Sha SH; Zheng Y
    Biomed Pharmacother; 2023 Oct; 166():115399. PubMed ID: 37657258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic Fibrosis and Oxidative Stress: The Role of CFTR.
    Moliteo E; Sciacca M; Palmeri A; Papale M; Manti S; Parisi GF; Leonardi S
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway.
    Liu S; Pi J; Zhang Q
    Redox Biol; 2022 Aug; 54():102389. PubMed ID: 35792437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme Oxygenase-1 Protects Hair Cells From Gentamicin-Induced Death.
    Yang Y; Chen X; Tian K; Tian C; Chen L; Mi W; Li Q; Qiu J; Lin Y; Zha D
    Front Cell Neurosci; 2022; 16():783346. PubMed ID: 35496911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of gentamicin-induced acute kidney injury by myo-inositol oxygenase via the ROS/ALOX-12/12-HETE/GPR31 signaling pathway.
    Sharma I; Liao Y; Zheng X; Kanwar YS
    JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acupuncture Attenuates Ototoxicity Induced by Gentamicin in Mice.
    Yu Y; Cao L; Guan N; Tang Y; Han M
    Altern Ther Health Med; 2022 Feb; 28(2):78-83. PubMed ID: 34847071
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.